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OBJECTIVE — The purpose of this study was to assess the virulence potential of Staphylo-
coccus aureus strains isolated from diabetic foot ulcers and to discriminate noninfected from
infected ulcers.
RESEARCH DESIGN AND METHODS — Diabetic patients hospitalized in a diabetic
foot department with a foot ulcer were prospectively enrolled if they had been free of
antibiotic treatment over the previous 6 months. At admission, ulcers were classiﬁed as
infected or noninfected on the basis of clinical examination, according to the International
Working Group on the Diabetic Foot system. Only patients carrying S. aureus as the sole
pathogenwereincluded.Inindividualswithagrade1ulcer,asecondbacterialspecimenwas
obtained 1 month later. Using virulence genotyping markers, clonality tools, and an in vivo
Caenorhabditiselegansmodel,wecorrelatedthevirulenceof132S.aureusstrainswithgrade,
time of collection, and ulcer outcome.
RESULTS — Amongvirulencegenes,themostrelevantcombinationderivedfromthelogistic
regression was the association of cap8, sea, sei, lukE, and hlgv (area under the curve 0.958).
Thesemarkerswereusefultodistinguishnoninfected(grade1)frominfected(grades2–4)ulcers
and to predict wound status at the follow-up. With use of the nematode model, S. aureus strains
isolated from grade 1 ulcers were found to be signiﬁcantly less virulent than strains from ulcers
at or above grade 2 (P  0.001).
CONCLUSIONS — This study highlights the coexistence of two S. aureus populations on
diabetic foot ulcers. A combination of ﬁve genes that may help distinguish colonized grade 1
from infected grade2 wounds, predict ulcer outcome, and contribute to more appropriate use
of antibiotics was discovered.
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F
oot ulcers are common in diabetic
patients, with prevalence as high as
25% (1). These ulcers frequently be-
come infected, and spread of infections to
soft tissue and to bony structures is a ma-
jor causal factor for lower-limb amputa-
tion (2). Early diagnosis and adequate
treatment are essential. Because microor-
ganisms are always present on skin
wounds, diagnosis of infection must be
basednotonmicrobiologicalﬁndingsbut
on clinical criteria, as emphasized by the
Infectious Diseases Society of America
and the International Working Group on
the Diabetic Foot (IWGDF) and more re-
centlybytheFrenchSocietyforInfectious
Pathology(3–5).However,becauseofthe
confounding impact of neuropathy and
ischemiaonlocalandsystemicinﬂamma-
toryresponse,diagnosingfootinfectionat
an early stage in diabetic individuals may
be difﬁcult.
Recently, we demonstrated the value
of using a miniaturized oligonucleotide
arraycoveringdifferentgenesofStaphylo-
coccus aureus, by far the most common
and virulent pathogen in diabetic foot in-
fection (3), and we showed that the viru-
lence gene proﬁle of S. aureus enables us
to distinguish grade 1 from grades 2–4
ulcers because the former generally dis-
played a very low level of virulence genes
(6). One of the main limitations in that
work was the limited panel of genes used.
Here we analyzed the most prevalent
virulence-associatedgenesandtheinvivo
virulence potential of the different S. au-
reus strains isolated from diabetic foot ul-
cers. The aim was to detect genetic
markers to distinguish noninfected and
infected ulcer and to predict outcome of
grade 1 ulcers.
RESEARCH DESIGN AND
METHODS— From 1 March 2004
through 31 July 2007, a prospective lon-
gitudinal study of patients with diabetic
foot ulcers at Nîmes University Hospital
was conducted as described previously
(6). Seventy-four patients (63%), hospi-
talized before or during April 2006, were
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approved by the local ethics committee
and performed in accordance with the
Declaration of Helsinki as revised in
2000.
Bacterial isolation
After wound debridement, samples for
bacterial culture were obtained by swab-
bing the wound base, needle aspiration,
or tissue biopsies and were sent immedi-
ately to the bacteriology department.
Only patients with monomicrobial cul-
tures positive for S. aureus were included
in the study. Patients with grade 1 ulcers
were closely followed over a period of 6
months to conﬁrm the wound status (in-
fected/noninfected ulcer). If the wound
healed, a microbiological specimen was
obtained 1 month later. If the wound did
not heal, antibiotic therapy was initiated
and surgical debridement or minor am-
putation was performed according to the
woundstatus;asampleforbacteriological
culture was obtained before antibiotic
treatment was begun and the ulcer grade
was updated.
Microbiological study
Genus, species, and antibiotic suscepti-
bilities were determined using the Vitek 2
card (bioMe ´rieux, Marcy-l’Etoile, France)
and interpreted according to the recom-
mendations of the French Society for
Microbiology (7). Susceptibility to meth-
icillin was screened by agar diffusion us-
ing cefoxitin disks (Bio-Rad, Marnes-La-
Coquette, France) (7).
Virulence proﬁle of S. aureus strains
To assess the virulence potential of
strains, the presence of 31 among the
most prevalent virulence-associated
genes was evaluated by PCR as described
previously (8,9): staphylococcal entero-
toxins A, B, C, D, E, G, H, I, J, K, and Q
(se), toxic shock syndrome toxin 1 (tst),
exfoliative toxins A and B (etA and etB),
Panton Valentine leukocidin (PVL) (lukS-
PV_lukF-PV), LukDE leukocidin (lukE),
- and two -hemolysins (hlb, hlg, and
hlgv),epidermalcelldifferentiationinhib-
itor (edinC), nine microbial surface com-
ponents recognizing adhesive matrix
molecules (MSCRAMM) (bbp, cna, ebpS,
clfA,clfB,ﬁb,fnbA,fnbB,andeno),andcap-
sular types 5 and 8 (cap5 and cap8). The
accessorygeneregulator(agr)allelegroup
was determined by multiplex PCR (10).
Clonality of S. aureus strains
To eliminate a bias in the distribution of
virulence genes due to the presence of
clonalbacteriaineachgrade,weuseddif-
ferent epidemiological methods. This
analysis also allowed us to compare
strains isolated at admission and during
follow-up to determine whether they
were identical.
Macrorestriction analysis of SmaI-
digested chromosomal DNA was per-
formedbypulsedﬁeldgelelectrophoresis
(PFGE) with the CHEF DRII system (Bio-
Rad) (11). The PFGE patterns were ana-
lyzed by GelCompar software (Applied
Math, Kortrijk, Belgium) and compared
by the algorithmic clustering method
known as the unweighted-pair group
method using arithmetic averages with
the Dice coefﬁcient of similarity.
Staphylococcalchromosomalcassette
(SCCmec) type was determined by PCR
typing according to a simpliﬁed strategy
of Kondo’s typing system without deter-
mining the differences in the junkyard
region (see supplemental glossary, avail-
able in an online appendix at http://dx
.doi.org/10.2337/dc08-1010) (12). The
spa sequence (see supplemental glossary)
typingwasperformedaccordingtotheRi-
dom Staph Type standard protocol
(http://www.ridom.com) and by using
the Ridom SpaServer, which automati-
cally analyzes spa repeats, assigns spa
types, and clusters related spa types in a
spa group (http://spa.ridom.de/index
.shtml).
Caenorhabditis elegans in vivo model
C. elegans (see supplemental glossary) has
been used to develop an easy model sys-
tem of host-pathogen interactions to
identify basic evolutionarily conserved
pathways associated with microbial
pathogenesis. This test is based on the ca-
pacity of pathogens ingested by C. elegans
nematodes to infect and ultimately kill
the worms (13). The survival of nema-
todes fed on different S. aureus strains is
an indirect marker of their virulence po-
tential. Fer-15 worms were infected as
previously described (14). In brief, nem-
atode growth medium plates were inocu-
lated with 10 l of an overnight culture
of S. aureus strains and incubated at 37°C
for 8 h. Between 25 and 30 C. elegans
worms were transferred from a lawn of
Escherichia coli OP50 to a lawn of the
bacteriumtobetested,incubatedat25°C,
and examined at 24-h intervals with a
stereomicroscope (Leica MS5) for viabil-
ity. Nematodes were classiﬁed as dead if
they failed to respond to touch. All exper-
iments were conducted in triplicate and
repeated at least ﬁve times for each se-
lected strain. S. aureus virulence was as-
sessed using the nematode survival curve
and calculating the LT50 and LT100 (the
times required to kill 50 and 100% of the
worms, respectively).
Statistical analysis
For each qualitative variable (virulence
genotyping), comparison between ulcer
grades was assessed using Fisher’s exact
test. The ability to diagnose infection of a
woundwasexpressedbysensitivity,spec-
iﬁcity, and positive and negative predic-
tive values; area under the receiver
operating characteristic (AUCROC) curve
was calculated by the nonparametric
Hanley method. To assess the utility of
combining several virulence markers, we
used a logistic regression with a back-
ward procedure to select the most rele-
vant markers; only markers for which
AUCROCwas0.80wereinitiallyentered
as explanatory variables in the regression
analysis. An ROC curve was then gener-
atedforthecombinationderivedfromthe
regression model, and its area was com-
pared with that of every single virulence
marker by a nonparametric method
adapted to paired data (15). To compare
overall survival curves in the nematode
killing assay, a Cox regression was used.
Statistical analysis was performed using
S-Plus 2000 software (Insightful, Seattle,
WA), and results were considered signif-
icant for P  0.05.
RESULTS
Clinical and bacteriological data
From 513 selected patients, 118 were in-
cluded because they had been free of any
antibiotic treatment for at least 6 months,
and S. aureus was the single organism iso-
lated from the bacterial culture of their
wound (Fig. 1). In 69, the current wound
was the ﬁrst episode of ulceration,
whereas in 49 it was a recurrence. The
characteristics of the study population
are shown in Fig. 1 and Table 1. Of the
wounds, 24 (20%) were classiﬁed as
grade 1 and were followed for 6 months.
Of the 118 S. aureus strains, 48 (41%)
were methicillin-resistant (MRSA). Dur-
ing the follow-up period, 9 grade 1 ulcers
healed (38%), whereas 15 worsened. In
two healing ulcers, samples remained
positive for S. aureus compared with pos-
itive results for 12 of the 15 nonhealed
ulcers. In total, 132 S. aureus strains were
Sotto and Associates
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and follow-up. In grade 1 ulcers, two genotyping proﬁles were obtained: proﬁle 1, without the four infection markers and with the noninfected ulcer
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14 during the follow-up period) (Fig. 1).
All recurrent ulcers were positive for
MRSA, whereas methicillin-susceptible S.
aureus (MSSA) was isolated in all but one
of the ulcers appearing as the ﬁrst epi-
sode. A higher prevalence of MRSA with
increasing severity of infection was also
noted, with a statically signiﬁcant differ-
ence for grade 1 compared with grades
2–4 (P  0.021).
Virulence proﬁle
Virulence genotyping of the 132 strains
evaluated by PCR is shown in Table 2.
Individual gene analysis showed that the
prevalence rates of 10 genes (sea, seb, sec,
sei, sej, hlb, hlg, hlgv, cap5, and lukE) were
signiﬁcantly more often associated with
strains isolated from grades 2–4 ulcers,
whereas the cap8 gene was most fre-
quently found in strains from grade 1 ul-
cers (P  0.05). From the logistic model
analysis, a ﬁve-gene combination of sea,
sei, lukE, hlgv, and cap8 was the most pre-
dictive for differentiating grade 1 from
grades 2–4 ulcers: mean  SD AUCROC
was 0.940  0.028 (95% CI 0.885–
0.995), which is signiﬁcantly greater
than that from combining all of the 30
virulence genes (0.810  0.078) (P 
0.05); sensitivity was 0.977  0.025,
speciﬁcity was 0.871  0.063, and posi-
tive and negative predictive values were
0.884 and 0.975, respectively. Using the
logisticregressionequation,threegrade1
ulcers were misclassiﬁed owing to ab-
senceofcap8butpresenceofsea,sei,lukE,
and hlgv genes; interestingly, these ulcers
rapidly worsened. Conversely, 17 grades
2–4 ulcers were misclassiﬁed owing to
absence of sea, sei, lukE, and hlgv genes.
Clonality study
By using PFGE, a wide genomic diversity
was shown among the 132 S. aureus iso-
lates (data not shown), allowing us to ex-
clude a bias in the statistical analysis.
PFGE also revealed the spread of three
clonal MRSA groups (44 strains; 33% of
theisolates).Amajorgroup,clustering29
strains (66% of MRSA strains) matched
theLyonclone(agrallele1,spatypet008,
and SCCmec type IV). The ﬁrst minor
clone (eight strains, 16% of MRSA) was
the “classic pediatric” clone (agr allele 2,
spatyperelatedtot311,andSCCmectype
IV). The second minor clone (three
strains, 6% of MRSA) was the “new pedi-
atric”clone(agr2allele,spatypet777,and
SCCmec type VI).
Comparison between strains isolated
frompatients’ulcersatadmissionandfol-
low-up demonstrated that those isolated
fromhealingandslowlyworseningulcers
hadnoclonallink.Ontheotherhand,the
strains from the three rapidly worsening
ulcers were similar in each ulcer (data not
shown).
S. aureus–mediated killing of
C. elegans
When feeding on E. coli OP50, C. elegans
has a 2-week life span (LT100 of worms
varying between 11 and 14 days and
LT50 between 3 and 5 days). When feed-
ing on a pathogen, worms die far more
rapidly, with a life span between 3 and 7
days (LT50 between 1 and 2 days).
Three strains (two MSSA and one
MRSA) chosen at random among those
isolated at admission in each of the four
ulcer grades were tested for their capacity
to kill C. elegans. In addition, strains ini-
tially isolated from grade 1 ulcers were
compared with those isolated at the fol-
low-up:strainsfromthreeulcerswithdif-
ferent outcomes were chosen: one that
healed, one that worsened rapidly, and
marker; and proﬁle 2, with presence of infection markers. During the follow-up, if the wound healed, the genotyping proﬁles (proﬁle 1) are the same
as the inclusion proﬁles. Also if a wound presented a slowly worsening evolution, the genotyping proﬁles (proﬁle 4) are different from the inclusion
proﬁle (proﬁle 1), with the four infection markers in all of the follow-up cases. On the other hand, if the wound presented a rapidly worsening
evolution, the genotyping proﬁles (proﬁle 2) are exactly the same in inclusion and follow-up with the four infection markers. *Grades according to
the IWGDF classiﬁcation system (3,4). Number of monomicrobial cultures for S. aureus (132  118  12  2) is in bold type.
Table 1—Demographic and clinical characteristics of study patients
Characteristics Value
Age (years) 68.0 (43–95)
Men/women 72 (61)/46 (39)
Type 1/type 2 diabetes 10/108
Diabetes duration (years) 18.4 (2–35)
A1C on admission (%) 7.4 (4.9–9.3)
Complications and comorbidities
Cardiovascular disease 71 (60)
Peripheral vascular disease 46 (39)
Neuropathy 95 (81)
Nephropathy 73 (62)
Retinopathy 65 (55)
Previous hospitalization 1 year 11 (15)
First presentation/recurrence 69/49
Wound depth
Superﬁcial 57 (48)
Deep 61 (52)
IWGDF grade
1 24 (20)
2 33 (28)
3 36 (31)
4 25 (21)
Microbial samples
Swab 65 (55.1)
Aspiration 29 (24.6)
Tissue biopsy 24 (20.3)
Wound outcome (6-month follow-up)
Healing 52 (44)
No healing 25 (21)
Revascularization procedure 29 (25)
Amputation 6 (5)
Death 2 (2)
No follow-up 0 (0)
Data are median (interquartile range: 25th–75th percentile) or n (%).
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cording to their killing ability, two popu-
lations of bacteria can be observed: the
ﬁrst with LT50 2 days, suggesting a
high virulence potential, and the second
with LT50 3 days, suggesting lower vir-
ulence (P  0.001). All of the strains with
LT50 2 days were isolated from ulcers
grades 2–4 except for one (NSA22465);
conversely, all of the strains but one with
LT50 3 days were isolated from grade 1
ulcers. Interestingly, no signiﬁcant differ-
enceinthekillingpotentialsofMRSAand
MSSA was observed within ulcers of the
samegrade:bothstrainsfromgrade1had
a similarly long LT50 (3.5  0.3 days),
and MRSA and MSSA from ulcers grades
2–4 had a similarly short LT50 (1.7 
0.2 days). Finally, both at entry and at
follow-up, the LT50 for strains isolated
from healing ulcers was relatively long
(3.7 vs. 3.6 days, NS), whereas it was
short for the strains from rapidly worsen-
ing ulcers (1.67 vs. 1.71 days, NS). For
the strain from a slowly worsening ulcer,
the LT50 was signiﬁcantly shorter at fol-
low-up than at admission (1.8 vs. 3.3
days, P  0.001).
CONCLUSIONS — This study dem-
onstratedfortheﬁrsttimetheexistenceof
two populations of S. aureus strains in di-
abetic foot ulcers: strains isolated from
noninfected ulcers with a low virulence
potential (as shown by the in vivo nema-
tode model results) as opposed to strains
isolated from infected ulcers with a high
virulence potential. Moreover, the pres-
ence or absence of ﬁve virulence genes
separated the two populations and al-
lowed us to distinguish noninfected from
infected wounds.
The fact that determining ﬁve viru-
lence genes may help to differentiate
noninfected from infected wound is
an attractive result. Among infection-
associated genes, four corresponded to
MRSA markers (sea, sei, lukE, and hlgv)
and hlgv, sea, and lukE-lukD genes are
shared in the Lyon clone. Moreover, hos-
pital-acquired MRSA strains shared the
enterotoxingeneclusterlocus,notablysei
(16). sea is the most studied and interest-
ing gene; its product has a strong proin-
ﬂammatory effect (17). In our study, this
gene was not exclusively related to the
virulenceofMRSAinfection,asitwasalso
detected in MSSA strains. Recently, an in-
nate immune evasion cluster located on
-hemolysin–converting bacteriophages
and carrying sea was discovered. It is eas-
ily transferred among strains (18). This
potential of transfer via bacteriophage
could explain our results and, notably,
the presence of the sea gene in MSSA
strains. The higher prevalence of sea, sei,
lukE, and hlgv genes among the strains
isolated from grades 2–4 compared with
grade 1 ulcers and the absence of differ-
ences in MRSA clones between grade 1
and grades 2–4 ulcers suggest that these
markers are really interesting, as they ac-
tually could be virulence markers. Fi-
nally, a number of studies demonstrated
that the noninfected ulcer marker, cap-
sular polysaccharide T8 (Cap8) was
strongly associated with MSSA strains, as
suggested by our study (19). However, its
role in virulence has not been clearly de-
ﬁned. Production of Cap8 appears to be
regulated by various environmental cues,
and its overproduction might be impli-
cated in S. aureus virulence (20,21).
Another interesting point is the low
levelofclonalstrainsisolatedinthisstudy
(33%). Among MRSA strains, results in-
dicated that a major clone matching the
Lyonclone(66%)waswidelydistributed.
Our study is in accordance with a recent
reportshowingthatthiscloneiscurrently
the most prevalent MRSA clone in France
Table2—Prevalenceofvirulencedeterminantsamongthe132S.aureusstrainsisolatedfrom
diabetic foot ulcers during inclusion and follow-up
Virulence
genotyping Grade 1 Grade 2 Grade 3 Grade 4
P value
Grade 1 vs.
Grade 2
Grade 1 vs.
G*
n 26 35 45 26
sea 3 (12) 16 (46) 29 (64) 14 (54) 0.015 0.001
seb 0 (0) 2 (6) 7 (16) 7 (27) 0.041
sec 0 (0) 5 (14) 4 (9) 9 (35) 0.023
sed 7 (27) 16 (46) 18 (40) 12 (46)
see 0 (0) 0 (0) 0 (0) 0 (0)
seg 6 (23) 10 (29) 18 (40) 16 (62)
seh 1 (4) 3 (9) 3 (7) 1 (4)
sei 5 (19) 12 (34) 20 (44) 18 (69) 0.014
sej 4 (15) 14 (40) 12 (27) 8 (31) 0.049
sek 0 (0) 3 (9) 1 (2) 3 (12)
seq 0 (0) 3 (9) 1 (2) 2 (8)
tst 2 (8) 4 (11) 7 (16) 12 (46)
etA 0 (0) 1 (3) 2 (4) 1 (4)
etB 0 (0) 0 (0) 0 (0) 0 (0)
luk-PV 0 (0) 0 (0) 2 (4) 3 (12)
lukE 7 (27) 23 (66) 23 (51) 17 (65) 0.004 0.004
hlb 7 (27) 17 (49) 29 (64) 17 (65) 0.004
hlg 3 (12) 23 (66) 36 (80) 21 (81) 0.001 0.001
hlgv 2 (8) 21 (60) 35 (78) 20 (77) 0.001 0.001
edinC 0 (0) 0 (0) 0 (0) 0 (0)
bbp 1 (4) 5 (14) 7 (16) 6 (23)
cna 3 (12) 4 (11) 5 (11) 8 (31)
ebpS 3 (12) 7 (20) 13 (29) 12 (46)
clfA 22 (85) 30 (86) 36 (80) 23 (89)
clfB 20 (77) 31 (89) 32 (71) 24 (92)
ﬁb 16 (62) 20 (57) 27 (60) 20 (77)
fnbA 5 (19) 14 (40) 13 (29) 13 (50)
fnbB 13 (50) 21 (60) 19 (42) 17 (65)
eno 26 (100) 35 (100) 45 (100) 26 (100)
cap5 9 (35) 23 (66) 28 (62) 16 (62) 0.021 0.014
cap8 15 (58) 5 (14) 6 (13) 3 (12) 0.019 0.002
agr1 10 (39) 24 (69) 21 (47) 13 (50)
agr2 10 (39) 5 (14) 11 (24) 6 (24)
agr3 6 (23) 4 (11) 7 (16) 7 (27)
agr4 0 (0) 2 (6) 6 (13) 0 (0)
MRSA 5 (19) 12 (34) 20 (44) 14 (54) 0.021
Data are n (%) unless otherwise indicated. *G corresponds to grades 2–4 according to the IWGDF classiﬁ-
cation system (3,4).
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tion of PVL-producing clones has been
extensively reported and discussed since
the beginning of the new millennium,
these strains were not detected in our
study.
The use of the C. elegans model dem-
onstrated that S. aureus virulence was
not dependent on methicillin resistance
as suggested previously (22,23). This re-
sult is interesting because nearly half of
the S. aureus strains isolated were methi-
cillin resistant. We can speculate that
within the same bacterial species there
arepathogenswithdifferentvirulencepo-
tential against the host. These bacterial
populations with variable virulence rep-
resent a new challenge in terms of patho-
genicity, treatment, and prevention of
transmission.
Ourstudysuggeststhattestingforthe
presence of ﬁve genes may not only help
clinicians to distinguish grade 1 from
grades 2–4 ulcers but will also predict
wound outcome. At follow-up, S. aureus
was isolated from 13 grade 1 ulcers. cap8
was detected in S. aureus from the two
healing ulcers, but the strains had pulso-
types and genotypes different from those
of the baseline sample. Three of the 15
worsening ulcers (corresponding to the
three false-positive results) rapidly de-
graded; both pulsotype and virulence
proﬁleswerefoundtobeunchanged,sug-
gestingthattheisolateswerethesameand
the wound was actually infected at base-
line and not simply colonized. Finally, S.
aureusfromslowlyworseningrecalcitrant
ulcers harbored virulence markers that
were absent at baseline: pulsotypes and
genotypes were different in every case,
suggesting that new, more virulent S. au-
reus strains had colonized the ulcer
(Fig. 1).
In summary, the increasing preva-
lence of resistant staphylococci and the
small number of new antimicrobial drugs
must stimulate the discovery of new solu-
tions for diabetic foot infections in the
near future. Testing for the presence of
ﬁve genes will be a useful tool in manage-
ment of diabetic foot ulcers. One-step
multiplex PCR assays are relatively easy
and rapid to perform (2 h after obtaining
a specimen) at low cost (	5 USD). This
testing will allow early discrimination be-
tween noninfected grade 1 and infected
grades 2–4 diabetic foot ulcers, such that
antibiotic treatment is prescribed for
those most likely to beneﬁt.
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Figure2—C.eleganskillingassay.A:ComparisonofLT50accordingtoIWGDFgradeandsusceptibilityofS.aureustomethicillin.B:Comparison
of LT50 of strains isolated from grade 1 ulcers at inclusion and on the same wound after follow-up: ulcer 1, healing ulcer (grade 1 followed by grade
1); ulcer 2, rapid worsening ulcer (grade 1 followed by grade 2); and ulcer 3, slow worsening ulcer (grade 1 followed by grade 3). Virulent bacteria
(isolated from ulcers grades 2–4) kill worms more quickly than avirulent strains (isolated from grade 1 ulcers). No statistically signiﬁcant
differences in LT50 were noted between MSSA and MRSA isolated from ulcers of the same grade. LT50 corresponds to the time for half of the worms
to die. A: o, MRSA; f, MSSA. 1, NSA6759 (n  6 virulence genes); 2, NSA43233 (n  3); 3, NSA56348 (n  2); 4, NSA443564 (n  15); 5,
NSA16210 (n  15); 6, NSA454193 (n  13); 7, NSA369602 (n  14); 8, NSA26758 (n  15); 9, NSA19308 (n  14); 10, NSA4281 (n  18);
11, NSA29197 (n  15); and 12, NSA41007 (n  10). B:  , at admission; f, after follow-up. 1, NSA11260 (n  4 virulence genes); 2, NSA739
(n6);3,NSA22465(n9);4,NSA27333(n9);5,NSA18026(n5);and6,NSA388104(n12).Theresultsarerepresentativeofatleast
ﬁve independent trials for each group of strains. I, strains isolated at inclusion; F, strains isolated at follow-up.
Sotto and Associates
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